What Has Been The Historical And Current Growth Of The Nasal Cannula Market?
The nasal cannula market has seen considerable growth due to a variety of factors.
• The size of the nasal cannula market has seen robust growth in the past few years. What was a $8.93 billion market in 2024 is expected to rise to $9.82 billion by 2025, with a compound annual growth rate (CAGR) of 9.9%.
Factors contributing to this historic growth include an increased emphasis on personalized patient care, a growing prevalence of obstructive sleep apnea, heightened awareness of respiratory diseases, lifestyle alterations, and a growing population.
What are the Market Size and Expected Growth Rates for the Nasal Cannula Market?
The nasal cannula market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of nasal cannula is projected to experience robust growth in the coming years, reaching $14.17 billion in 2029 with a compound annual growth rate (CAGR) of 9.6%.
This growth during the forecast period is associated with factors such as the rising incidence of respiratory diseases, growing health care spending, increasing elderly population, more government initiatives, and a rise in surgical procedures. Key trends expected over the forecast period are advancements in technology, strategic partnerships, expansion of facilities, investments in R&D, and a focus on introducing new products.
What Are The Key Drivers Fueling Growth In The Nasal Cannula Market?
The escalation in cases of respiratory diseases is making a substantial contribution to the advancement of the nasal cannula market. These diseases, which affect the lungs and airways, interfere with breathing and the exchange of oxygen. The ascent in these ailments can be credited to factors like air pollution, smoking, viral infections, and greater exposure to allergens. The nasal cannula is employed in cases of respiratory diseases to provide extra oxygen straight into the nostrils, thus enhancing oxygen levels in patients who have difficulty breathing. To illustrate, in June 2024, the American Lung Association, a non-profit organization based in the US, stated that around 44.2 million Americans, representing 13.5% of the population, reported being diagnosed with asthma by a certified health professional in 2022. Consequently, the upsurge in respiratory diseases propels the growth of the nasal cannula market.
How Is The Globa Nasal Cannula Market Divided Into Key Segments?
The nasal cannula market covered in this report is segmented –
1) By Type: Low Flow Nasal Cannula, High Flow Nasal Cannula
2) By Material: Plastic, Silicone
3) By Size: Neonate, Infant, Child, Adult
4) By Prongs: Straight, Curved, Flared, Other Prongs
5) By End User: Hospitals, Ambulatory Healthcare Services, Long Term Care Centers, Others End Users
Subsegments:
1) By Low Flow Nasal Cannula: Adult Low Flow Nasal Cannula, Pediatric Low Flow Nasal Cannula, Disposable Low Flow Nasal Cannula, Reusable Low Flow Nasal Cannula
2) By High Flow Nasal Cannula: Adult High Flow Nasal Cannula, Pediatric High Flow Nasal Cannula, Disposable High Flow Nasal Cannula, Reusable High Flow Nasal Cannula
Pre-Book The Nasal Cannula Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Nasal Cannula Market?
Pioneering corporations in the nasal cannula market are concentrating on technological innovations like low-flow nasal cannulas. These advancements are meant to augment patient convenience, optimize the efficiency of oxygen supply, and cater to distinct clinical needs. A low-flow nasal cannula is specifically designed to provide supplemental oxygen at reduced flow rates, typically between 1 to 6 liters per minute, using two prongs placed into the nostrils. For example, CNSAC MedShop, a diagnostics and consumables firm based in Germany, launched NasalOxy in May 2024. NasalOxy, a groundbreaking, patented low-flow nasal cannula, is designed to overcome the drawbacks of conventional oxygen delivery systems. With this innovative device, patients needing long-term oxygen treatment can experience unparalleled comfort and efficacy. It also allows for flexibility in facilitating both nasal and oral breathing. The superior design of NasalOxy lessens contact with the mucous membrane, thus significantly reducing irritation and discomfort and removing the common adverse effects of standard nasal cannulas.
Who Are the Key Players in the Nasal Cannula Market?
Major companies operating in the nasal cannula market are include:
• Cardinal Health Inc.
• Medline Industries Inc.
• Becton Dickinson and Company
• ResMed Inc.
• Teleflex Incorporated
• Angiplast Pvt. Ltd.
• Fisher & Paykel Healthcare Limited
• Drive DeVilbiss Healthcare LLC
• Well Lead Medical Co. Ltd.
• GaleMed Corp.
• Vapotherm Inc.
• Salter Labs Inc.
• Dynarex Corporation
• Mais India Medical Devices Pvt. Ltd.
• Allied Medical LLC
• Besmed Health Business Corp.
• Flexicare Medical Ltd.
• Medin Medical Innovations AB
• Airways Surgical Pvt. Ltd.
• Great Group Medical Co. Ltd.
• HUM GmbH
What are the Regional Insights into the Nasal Cannula Market?
North America was the largest region in the nasal cannula market in 2024. The regions covered in the nasal cannula market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
